Veracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $18.6 million versus the consensus estimate of $16.72 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.